Morglin-M Tablet ER
Morglin-M Tablet ER
Metformin (500mg) + Teneligliptin (20mg)
Ecoglip-TM Tablet PR
Ozone Pharmaceuticals Ltd
Metformin 500mg
Pack Size
1 units
Price
Save ₹58
that's 61% off!
About This Medicine
Product description & overview
Morglin-M Extended Release Tablet
Morglin-M Tablets ER contain a carefully-proportioned blend of Metformin (500mg) and Teneligliptin (20mg), combined in a single extended-release formulation for optimal blood sugar management. This innovative dosage structure provides steady control over glucose levels without the need for multiple doses throughout the day.
Morglin-M ER Tablets are designed for individuals struggling with Type 2 Diabetes. The combination of Metformin and Teneligliptin helps regulate blood glucose by inhibiting hepatic glucose production (Metformin) and enhancing insulin sensitivity (Teneligliptin).
This medication is taken once daily, simplifying patient adherence. It's important to follow your healthcare professional's prescription for proper dosage and duration of use.
Active composition
Metformin 500 mg
+1 more active ingredient
About Metformin
Metformin is an oral antihyperglycemic agent used to manage type 2 diabetes mellitus. It works by decreasing glucose production in the liver and improving insulin sensitivity. Metformin is effective in controlling blood sugar levels and preventing diabetes-related complications. In summary, Metformin is vital for managing type 2 diabetes.
How It Works
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
All Active Ingredients
Teneligliptin
Teneligliptin inhibits DPP-4, increasing incretin levels and enhancing insulin secretion.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
Morglin-M Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Pregnancy
Morglin-M Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Driving
Morglin-M Tablet ER should be used with caution in patients with kidney disease. Dose adjustment of Morglin-M Tablet ER may be needed. Please consult your doctor. Use of Morglin-M Tablet ER is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Exercise Caution
Breastfeeding
It is not known whether Morglin-M Tablet ER alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
Kidney
Morglin-M Tablet ER is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Morglin-M Tablet ER